Viral Vector Packaging Services refer to specialized services that provide the packaging of genetic material into viral vectors for various research, therapeutic, and industrial applications. Viral vectors are commonly used tools in gene therapy, gene delivery, vaccine development, and other genetic engineering applications. Viral vector packaging services offer researchers and biotech companies a convenient and reliable solution for obtaining high-quality viral vectors without the need for extensive infrastructure and expertise in vector production. These services accelerate research and development efforts in gene therapy, vaccine development, and other genetic engineering applications, ultimately advancing the field of biotechnology and medicine.
The global market for Viral Vector Packaging Services was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Viral Vector Packaging Services was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Viral Vector Packaging Services was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Viral Vector Packaging Services was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Viral Vector Packaging Services include Generon, OriGene, Charles River, SYSTEM BIOSCIENCES (SBI), Takara Bio, SignaGen Laboratories, VectorBuilder, Horizo??n Discovery Ltd. and Cellecta, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Viral Vector Packaging Services, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Viral Vector Packaging Services by region & country, by Type, and by Application.
The Viral Vector Packaging Services market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Vector Packaging Services.
麻豆原创 Segmentation
By Company
Generon
OriGene
Charles River
SYSTEM BIOSCIENCES (SBI)
Takara Bio
SignaGen Laboratories
VectorBuilder
Horizo??n Discovery Ltd.
Cellecta
Cayman Chemical Company
PackGene
Cell Biolabs
WZ Biosciences
Applied Biological Materials (abm)
金斯瑞生物科技股份有限公司
药明康德
Segment by Type:
Small-scale
Medium-scale
Large-scale
Segment by Application
Gene Therapy
Cell Therapy
Drug Research & Development
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Viral Vector Packaging Services manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Viral Vector Packaging Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Viral Vector Packaging Services in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Viral Vector Packaging Services Product Introduction
1.2 Global Viral Vector Packaging Services 麻豆原创 Size Forecast
1.3 Viral Vector Packaging Services 麻豆原创 Trends & Drivers
1.3.1 Viral Vector Packaging Services Industry Trends
1.3.2 Viral Vector Packaging Services 麻豆原创 Drivers & Opportunity
1.3.3 Viral Vector Packaging Services 麻豆原创 Challenges
1.3.4 Viral Vector Packaging Services 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Viral Vector Packaging Services Players Revenue Ranking (2023)
2.2 Global Viral Vector Packaging Services Revenue by Company (2019-2024)
2.3 Key Companies Viral Vector Packaging Services Manufacturing Base Distribution and Headquarters
2.4 Key Companies Viral Vector Packaging Services Product Offered
2.5 Key Companies Time to Begin Mass Production of Viral Vector Packaging Services
2.6 Viral Vector Packaging Services 麻豆原创 Competitive Analysis
2.6.1 Viral Vector Packaging Services 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Viral Vector Packaging Services Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Packaging Services as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Small-scale
3.1.2 Medium-scale
3.1.3 Large-scale
3.2 Global Viral Vector Packaging Services Sales Value by Type
3.2.1 Global Viral Vector Packaging Services Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Viral Vector Packaging Services Sales Value, by Type (2019-2030)
3.2.3 Global Viral Vector Packaging Services Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Gene Therapy
4.1.2 Cell Therapy
4.1.3 Drug Research & Development
4.1.4 Others
4.2 Global Viral Vector Packaging Services Sales Value by Application
4.2.1 Global Viral Vector Packaging Services Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Viral Vector Packaging Services Sales Value, by Application (2019-2030)
4.2.3 Global Viral Vector Packaging Services Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Viral Vector Packaging Services Sales Value by Region
5.1.1 Global Viral Vector Packaging Services Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Viral Vector Packaging Services Sales Value by Region (2019-2024)
5.1.3 Global Viral Vector Packaging Services Sales Value by Region (2025-2030)
5.1.4 Global Viral Vector Packaging Services Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Viral Vector Packaging Services Sales Value, 2019-2030
5.2.2 North America Viral Vector Packaging Services Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Viral Vector Packaging Services Sales Value, 2019-2030
5.3.2 Europe Viral Vector Packaging Services Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Viral Vector Packaging Services Sales Value, 2019-2030
5.4.2 Asia Pacific Viral Vector Packaging Services Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Viral Vector Packaging Services Sales Value, 2019-2030
5.5.2 South America Viral Vector Packaging Services Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Viral Vector Packaging Services Sales Value, 2019-2030
5.6.2 Middle East & Africa Viral Vector Packaging Services Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Viral Vector Packaging Services Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Viral Vector Packaging Services Sales Value
6.3 United States
6.3.1 United States Viral Vector Packaging Services Sales Value, 2019-2030
6.3.2 United States Viral Vector Packaging Services Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Viral Vector Packaging Services Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Viral Vector Packaging Services Sales Value, 2019-2030
6.4.2 Europe Viral Vector Packaging Services Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Viral Vector Packaging Services Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Viral Vector Packaging Services Sales Value, 2019-2030
6.5.2 China Viral Vector Packaging Services Sales Value by Type (%), 2023 VS 2030
6.5.3 China Viral Vector Packaging Services Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Viral Vector Packaging Services Sales Value, 2019-2030
6.6.2 Japan Viral Vector Packaging Services Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Viral Vector Packaging Services Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Viral Vector Packaging Services Sales Value, 2019-2030
6.7.2 South Korea Viral Vector Packaging Services Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Viral Vector Packaging Services Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Viral Vector Packaging Services Sales Value, 2019-2030
6.8.2 Southeast Asia Viral Vector Packaging Services Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Viral Vector Packaging Services Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Viral Vector Packaging Services Sales Value, 2019-2030
6.9.2 India Viral Vector Packaging Services Sales Value by Type (%), 2023 VS 2030
6.9.3 India Viral Vector Packaging Services Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Generon
7.1.1 Generon Profile
7.1.2 Generon Main Business
7.1.3 Generon Viral Vector Packaging Services Products, Services and Solutions
7.1.4 Generon Viral Vector Packaging Services Revenue (US$ Million) & (2019-2024)
7.1.5 Generon Recent Developments
7.2 OriGene
7.2.1 OriGene Profile
7.2.2 OriGene Main Business
7.2.3 OriGene Viral Vector Packaging Services Products, Services and Solutions
7.2.4 OriGene Viral Vector Packaging Services Revenue (US$ Million) & (2019-2024)
7.2.5 OriGene Recent Developments
7.3 Charles River
7.3.1 Charles River Profile
7.3.2 Charles River Main Business
7.3.3 Charles River Viral Vector Packaging Services Products, Services and Solutions
7.3.4 Charles River Viral Vector Packaging Services Revenue (US$ Million) & (2019-2024)
7.3.5 SYSTEM BIOSCIENCES (SBI) Recent Developments
7.4 SYSTEM BIOSCIENCES (SBI)
7.4.1 SYSTEM BIOSCIENCES (SBI) Profile
7.4.2 SYSTEM BIOSCIENCES (SBI) Main Business
7.4.3 SYSTEM BIOSCIENCES (SBI) Viral Vector Packaging Services Products, Services and Solutions
7.4.4 SYSTEM BIOSCIENCES (SBI) Viral Vector Packaging Services Revenue (US$ Million) & (2019-2024)
7.4.5 SYSTEM BIOSCIENCES (SBI) Recent Developments
7.5 Takara Bio
7.5.1 Takara Bio Profile
7.5.2 Takara Bio Main Business
7.5.3 Takara Bio Viral Vector Packaging Services Products, Services and Solutions
7.5.4 Takara Bio Viral Vector Packaging Services Revenue (US$ Million) & (2019-2024)
7.5.5 Takara Bio Recent Developments
7.6 SignaGen Laboratories
7.6.1 SignaGen Laboratories Profile
7.6.2 SignaGen Laboratories Main Business
7.6.3 SignaGen Laboratories Viral Vector Packaging Services Products, Services and Solutions
7.6.4 SignaGen Laboratories Viral Vector Packaging Services Revenue (US$ Million) & (2019-2024)
7.6.5 SignaGen Laboratories Recent Developments
7.7 VectorBuilder
7.7.1 VectorBuilder Profile
7.7.2 VectorBuilder Main Business
7.7.3 VectorBuilder Viral Vector Packaging Services Products, Services and Solutions
7.7.4 VectorBuilder Viral Vector Packaging Services Revenue (US$ Million) & (2019-2024)
7.7.5 VectorBuilder Recent Developments
7.8 Horizo??n Discovery Ltd.
7.8.1 Horizo??n Discovery Ltd. Profile
7.8.2 Horizo??n Discovery Ltd. Main Business
7.8.3 Horizo??n Discovery Ltd. Viral Vector Packaging Services Products, Services and Solutions
7.8.4 Horizo??n Discovery Ltd. Viral Vector Packaging Services Revenue (US$ Million) & (2019-2024)
7.8.5 Horizo??n Discovery Ltd. Recent Developments
7.9 Cellecta
7.9.1 Cellecta Profile
7.9.2 Cellecta Main Business
7.9.3 Cellecta Viral Vector Packaging Services Products, Services and Solutions
7.9.4 Cellecta Viral Vector Packaging Services Revenue (US$ Million) & (2019-2024)
7.9.5 Cellecta Recent Developments
7.10 Cayman Chemical Company
7.10.1 Cayman Chemical Company Profile
7.10.2 Cayman Chemical Company Main Business
7.10.3 Cayman Chemical Company Viral Vector Packaging Services Products, Services and Solutions
7.10.4 Cayman Chemical Company Viral Vector Packaging Services Revenue (US$ Million) & (2019-2024)
7.10.5 Cayman Chemical Company Recent Developments
7.11 PackGene
7.11.1 PackGene Profile
7.11.2 PackGene Main Business
7.11.3 PackGene Viral Vector Packaging Services Products, Services and Solutions
7.11.4 PackGene Viral Vector Packaging Services Revenue (US$ Million) & (2019-2024)
7.11.5 PackGene Recent Developments
7.12 Cell Biolabs
7.12.1 Cell Biolabs Profile
7.12.2 Cell Biolabs Main Business
7.12.3 Cell Biolabs Viral Vector Packaging Services Products, Services and Solutions
7.12.4 Cell Biolabs Viral Vector Packaging Services Revenue (US$ Million) & (2019-2024)
7.12.5 Cell Biolabs Recent Developments
7.13 WZ Biosciences
7.13.1 WZ Biosciences Profile
7.13.2 WZ Biosciences Main Business
7.13.3 WZ Biosciences Viral Vector Packaging Services Products, Services and Solutions
7.13.4 WZ Biosciences Viral Vector Packaging Services Revenue (US$ Million) & (2019-2024)
7.13.5 WZ Biosciences Recent Developments
7.14 Applied Biological Materials (abm)
7.14.1 Applied Biological Materials (abm) Profile
7.14.2 Applied Biological Materials (abm) Main Business
7.14.3 Applied Biological Materials (abm) Viral Vector Packaging Services Products, Services and Solutions
7.14.4 Applied Biological Materials (abm) Viral Vector Packaging Services Revenue (US$ Million) & (2019-2024)
7.14.5 Applied Biological Materials (abm) Recent Developments
7.15 金斯瑞生物科技股份有限公司
7.15.1 金斯瑞生物科技股份有限公司 Profile
7.15.2 金斯瑞生物科技股份有限公司 Main Business
7.15.3 金斯瑞生物科技股份有限公司 Viral Vector Packaging Services Products, Services and Solutions
7.15.4 金斯瑞生物科技股份有限公司 Viral Vector Packaging Services Revenue (US$ Million) & (2019-2024)
7.15.5 金斯瑞生物科技股份有限公司 Recent Developments
7.16 药明康德
7.16.1 药明康德 Profile
7.16.2 药明康德 Main Business
7.16.3 药明康德 Viral Vector Packaging Services Products, Services and Solutions
7.16.4 药明康德 Viral Vector Packaging Services Revenue (US$ Million) & (2019-2024)
7.16.5 药明康德 Recent Developments
8 Industry Chain Analysis
8.1 Viral Vector Packaging Services Industrial Chain
8.2 Viral Vector Packaging Services Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Viral Vector Packaging Services Sales Model
8.5.2 Sales Channel
8.5.3 Viral Vector Packaging Services Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Generon
OriGene
Charles River
SYSTEM BIOSCIENCES (SBI)
Takara Bio
SignaGen Laboratories
VectorBuilder
Horizo??n Discovery Ltd.
Cellecta
Cayman Chemical Company
PackGene
Cell Biolabs
WZ Biosciences
Applied Biological Materials (abm)
金斯瑞生物科技股份有限公司
药明康德
?
?
*If Applicable.